Specifically the European Medicines Evaluation Agency’s (EMEA) Committee for Orphan Medicinal Products adopted a positive opinion on the company’s application to designate sapacitabine as an orphan medicinal product
Gleevec a targeted tyrosine kinase inhibitor drug is said to be a highly effective front line therapy for the treatment of chronic mylogenous leukemia (CML). The drug blocks
Under this agreement, Exiqon will use its miRCURY, LNA products to discover microRNA biomarkers. Specifically, the project focuses on identifying miRNA expression signatures associated with relapse and progression
Amitiza has a mechanism of action that works locally in the intestine to increase fluid secretion, resulting in increased passage of stool and alleviating symptoms associated with chronic
Myelin Repair Foundation’s (MRF) Accelerated Research Collaboration (ARC) model creates a unique partnership between academic researchers, scientific and drug discovery advisors and a centralized management team to define
The objective of the formal pharmacokinetic (PK) study was to support identification of an alternative dosing formulation of Zenvia to deliver similar efficacy as observed in the first
The study is ongoing at clinics in the US and will assess the safety, tolerability and pharmacokinetics of Factor IXFc (FIXFc) in this patient population. This FIXFc compound,
This was the fourth of several regularly scheduled reviews by the data safety monitoring board (DSMB) that will occur over the duration of the trial. The purpose of
TenoMend collagen tendon wrap is a resorbable type 1 collagen matrix that provides a non-constricting encasement for injured tendons. It is designed to be an interface between the
Impliant voluntarily suspended enrollment in the study in September 2007 following one device-related failure. After an extensive investigation conducted by a third-party expert in medical device retrievals and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.